These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1548675)

  • 1. Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors.
    de Laszlo SE; Bush BL; Doyle JJ; Greenlee WJ; Hangauer DG; Halgren TA; Lynch RJ; Schorn TW; Siegl PK
    J Med Chem; 1992 Mar; 35(5):833-46. PubMed ID: 1548675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
    Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
    J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of orally active glycol renin inhibitors containing phenyllactic acid at P3.
    Hanson GJ; Baran JS; Lowrie HS; Russell MA; Sarussi SJ; Williams K; Babler M; Bittner SE; Papaioannou SE; Yang PC
    Biochem Biophys Res Commun; 1989 Apr; 160(1):1-5. PubMed ID: 2496685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New modified heterocyclic phenylalanine derivatives. Incorporation into potent inhibitors of human renin.
    Ocain TD; Deininger DD; Russo R; Senko NA; Katz A; Kitzen JM; Mitchell R; Oshiro G; Russo A; Stupienski R
    J Med Chem; 1992 Mar; 35(5):823-32. PubMed ID: 1548674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desulfonylative radical ring closure onto aromatics. A modular route to benzazepin-2-ones and 5-arylpiperidin-2-ones.
    Charrier N; Liu Z; Zard SZ
    Org Lett; 2012 Apr; 14(8):2018-21. PubMed ID: 22463494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
    J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally constrained renin inhibitory peptides: gamma-lactam-bridged dipeptide isostere as conformational restriction.
    Thaisrivongs S; Pals DT; Turner SR; Kroll LT
    J Med Chem; 1988 Jul; 31(7):1369-76. PubMed ID: 3290485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
    Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
    J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.
    Hui KY; Carlson WD; Bernatowicz MS; Haber E
    J Med Chem; 1987 Aug; 30(8):1287-95. PubMed ID: 3302256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally constrained renin inhibitory peptides: cyclic (3-1)-1-(carboxymethyl)-L-prolyl-L-phenylalanyl-L-histidinamide as a conformational restriction at the P2-P4 tripeptide portion of the angiotensinogen template.
    Thaisrivongs S; Blinn JR; Pals DT; Turner SR
    J Med Chem; 1991 Apr; 34(4):1276-82. PubMed ID: 2016704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
    Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
    J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.
    Plattner JJ; Marcotte PA; Kleinert HD; Stein HH; Greer J; Bolis G; Fung AK; Bopp BA; Luly JR; Sham HL
    J Med Chem; 1988 Dec; 31(12):2277-88. PubMed ID: 3143010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of potent substrate-analogue inhibitors of canine renin.
    Hui KY; Siragy HM; Haber E
    Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
    Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin.
    Göschke R; Stutz S; Rasetti V; Cohen NC; Rahuel J; Rigollier P; Baum HP; Forgiarini P; Schnell CR; Wagner T; Gruetter MG; Fuhrer W; Schilling W; Cumin F; Wood JM; Maibaum J
    J Med Chem; 2007 Oct; 50(20):4818-31. PubMed ID: 17824679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
    Winiecka I; Jaworski P; Mazurek AP; Marszałek D; Goldnik A; Sokulski D
    J Pept Sci; 2016 Feb; 22(2):106-15. PubMed ID: 26780837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of rat renin inhibitory peptides.
    Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
    J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New potential renin inhibitors with dipeptide replacements in the molecule.
    Winiecka I; Dudkiewicz-Wilczyńska J; Roman I; Paruszewski R
    Acta Pol Pharm; 2010; 67(4):367-74. PubMed ID: 20635532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.